MetaCap

Azora Therapeutics Quarterly Cash Flow Statement

NASDAQ: AZRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.85-0.02 (-0.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Azora Therapeutics free cash flow

In the quarter ended Sep 30, 2026, Azora Therapeutics generated -$6.6 million of operating cash flow. That left free cash flow of -$6.6 million.

Summary generated from market data by MetaCap's automated system. Methodology

Azora Therapeutics cash flow statement (quarterly)

Azora Therapeutics quarterly cash flow statement
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q2 20242024-03-31Q4 20232023-12-31
Net Income-64.56M-51.99M-2.02M-2.00M-1.79M-1.96M-2.23M-2.07M-2.19M-2.46M-6.48M-1.92M
Net Income growth (YoY)—————————-325.99%——
Stock-Based Compensation958.00K137.10K147.90K168.20K147.00K124.27K236.73K180.20K188.26K202.38K225.99K280.85K
Change in Working Capital-230.00K-716.98K193.98K251.87K-264.00K19.62K408.38K278.10K-54.04K185.91K67.90K180.90K
Operating Cash Flow-6.63M-6.36M-1.61M-1.32M-1.83M-1.75M-1.59M-1.45M-1.69M-2.15M-1.63M-1.22M
Investing Cash Flow0——000150.00K————350.00K
Share Repurchases———————————0
Financing Cash Flow-35.00K25.21M315.28K2.60M525.00K5.30M50.65K03.61M411.09K3.82M3.38M
Net Change in Cash-6.67M24.13M-1.30M1.27M-1.31M3.55M-1.38M-1.45M1.92M-1.74M2.20M2.51M
Free Cash Flow-6.63M-6.36M-1.61M-1.32M-1.83M-1.75M-1.59M-1.45M-1.69M-2.15M-1.63M-1.22M

This table shows 12 quarterly periods of Azora Therapeutics's cash flow statement, from Q3 2026 back to Q4 2023, across 12 line items including net income, stock-based compensation, change in working capital. Values in USD; B = billions, M = millions. Fiscal periods follow AZR's reporting calendar. What is a cash flow statement?

More financial data